ACTIV-2 (BRII-196 and BRII-198), 0 NCT04518410
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) vs. placebo
COVID 19 outpatients
OPTIMISE-C19 (bamlanivimab monotherapy vs casirivimab-imdevimab), 2021 NCT04790786
bamlanivimab monotherapy vs. casirivimab/imdevimab (Ronapreve)
COVID 19 outpatients
Bariola, 2021
bamlanivimab monotherapy vs. control
COVID 19 outpatients
BLAZE-1 phase 2 (monotherapy), 2020 NCT04427501
bamlanivimab monotherapy vs. placebo
COVID 19 outpatients
ACTIV-2 bamlanivimab, 0 NCT04518410
bamlanivimab monotherapy vs. placebo
COVID 19 outpatients
Rainwater-Lovett, 2021
bamlanivimab monotherapy vs. standard of care
COVID 19 outpatients
OPTIMISE-C19 (bamlanivimab-etesevimab vs casirivimab-imdevimab), 2021 NCT04790786
bamlanivimab/etesevimab vs. casirivimab/imdevimab (Ronapreve)
COVID 19 outpatients
BLAZE-1 phase 2 (combination with etesevimab), 2020 NCT04427501
bamlanivimab/etesevimab vs. placebo
COVID 19 outpatients
BLAZE-1 phase 3 (combo), 2021 NCT04427501
bamlanivimab/etesevimab vs. placebo
COVID 19 outpatients
BLAZE-4, 0 NCT04634409
bamlanivimab/etesevimab vs. placebo
COVID 19 outpatients
BLAZE 4 LY-CoV1404, 0 NCT04634409
Bebtelovimab (LY-CoV1404) vs. placebo
COVID 19 outpatients
PRINCIPLE, 2021 ISRCTN86534580
budesonide vs. standard of care
COVID 19 outpatients
STOIC, 2021 NCT04416399
budesonide vs. standard of care
COVID 19 outpatients
Mazzotta, 2022
casirivimab/imdevimab (Ronapreve) vs. bamlanivimab/etesevimab
COVID 19 outpatients
Cov-2069 (Cohort B: positive SARS-CoV-2 RT-qPCR test result), 2021 NCT04452318
casirivimab/imdevimab (Ronapreve) vs. placebo
COVID 19 outpatients
Cov-2067 Weinreich (1200mg) Cohort 1, 2020 NCT04425629
casirivimab/imdevimab (Ronapreve) vs. placebo
COVID 19 outpatients
O'Brien (Part B: recently infected asymptomatic patients), 2021 NCT04452318
casirivimab/imdevimab (Ronapreve) vs. placebo
COVID 19 outpatients
Clemency, 2021 NCT04377711
ciclesonide vs. placebo
COVID 19 outpatients
Ezer N (CONTAIN), 2021 NCT04435795
ciclesonide vs. placebo
COVID 19 outpatients
TACKLE, 0 NCT04723394
cilgavimab and tixagevimab (Evusheld) vs. placebo
COVID 19 outpatients
COLCORONA, 2021 NCT04322682
colchicine vs. placebo
COVID 19 outpatients
PRINCIPLE (COLCHICINE), 2021 ISRCTN86534580
colchicine vs. standard of care
COVID 19 outpatients
C3PO, 2020 NCT04355767
convalescent plasma treatment vs. placebo
COVID 19 outpatients
CONV-ERT, 2021 NCT04621123
convalescent plasma treatment vs. placebo
COVID 19 outpatients
CoV-Early (Gharbharan), 2022 NCT04589949
convalescent plasma treatment vs. placebo
COVID 19 outpatients
CoV-Early (Gharbharan), 2022 NCT04589949
Early convalescent plasma. vs. placebo
COVID 19 outpatients
Webb, 2021
neutralizing antibody vs. control
COVID 19 outpatients
TOGETHER interferon lambda, 2022 NCT04727424
peginterferon vs. placebo
COVID 19 outpatients
Feld, 2021 NCT04354259
peginterferon vs. placebo
COVID 19 outpatients
CT-P59 1.2, 2020 NCT04593641
regdanvimab (Regkirona- CT-P59-Celltrion) vs. placebo
COVID 19 outpatients
CT-P59 3.2 part 1, 2021 NCT04602000
regdanvimab (Regkirona- CT-P59-Celltrion) vs. placebo
COVID 19 outpatients
CT-P59 3.2 part 2, 2021 NCT04602000
regdanvimab (Regkirona- CT-P59-Celltrion) vs. placebo
COVID 19 outpatients
ACTIV-2 SNG001, 2022 NCT04518410
SNG001 inhaled interferon beta vs. placebo
COVID 19 outpatients
COMET-ICE, 2021 NCT04545060
sotrovimab (Xevudy; VIR-7831) vs. placebo
COVID 19 outpatients
